Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions for REPLIGEN CORP (RGEN)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
RGENREPLIGEN CORPBylund JamesChief Operating OfficerApr 02, 2024Option Exercise$182.9544481,23020,591Apr 04, 2024, 05:04 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DMar 11, 2024Sale$165.164,788790,78127,777Mar 12, 2024, 08:24 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerMar 08, 2024Sale$197.4316,7083,298,649201,956Mar 11, 2024, 07:43 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerMar 07, 2024Option Exercise$195.722,867561,129201,955Mar 07, 2024, 04:28 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DMar 07, 2024Option Exercise$195.7238675,54826,506Mar 07, 2024, 04:27 PM
RGENREPLIGEN CORPBylund JamesChief Operating OfficerMar 07, 2024Option Exercise$195.721,206236,03821,035Mar 07, 2024, 04:23 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksMar 07, 2024Option Exercise$195.7238675,54827,753Mar 07, 2024, 04:22 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerMar 04, 2024Option Exercise$193.991,111215,523212,097Mar 06, 2024, 08:23 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerMar 05, 2024Option Exercise$195.527,2751,422,408204,822Mar 06, 2024, 08:23 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksMar 04, 2024Option Exercise$193.9913125,41328,139Mar 06, 2024, 08:07 PM
RGENREPLIGEN CORPBylund JamesChief Operating OfficerMar 04, 2024Option Exercise$193.9919738,21622,263Mar 06, 2024, 08:06 PM
RGENREPLIGEN CORPBylund JamesChief Operating OfficerMar 05, 2024Option Exercise$195.52224,30122,241Mar 06, 2024, 08:06 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DMar 04, 2024Option Exercise$193.9913526,18926,892Mar 06, 2024, 08:01 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DMar 01, 2024Option Exercise$191.7945386,88127,027Mar 04, 2024, 09:51 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerMar 01, 2024Option Exercise$191.793,322637,126213,208Mar 04, 2024, 09:49 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksMar 01, 2024Option Exercise$191.7944785,73028,731Mar 04, 2024, 09:45 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksMar 04, 2024Option Exercise$192.7146188,83928,270Mar 04, 2024, 09:45 PM
RGENREPLIGEN CORPBylund JamesChief Operating OfficerMar 01, 2024Option Exercise$191.79820157,26822,410Mar 04, 2024, 09:45 PM
RGENREPLIGEN CORPDAWES KAREN ADirectorFeb 27, 2024Sale$68.965,626387,96688,367Feb 28, 2024, 09:56 PM
RGENREPLIGEN CORPBylund JamesChief Operating OfficerFeb 23, 2024Sale$179.725,313954,87418,508Feb 26, 2024, 08:38 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksNov 10, 2023Sale$147.133,788557,32828,787Nov 13, 2023, 05:10 PM
RGENREPLIGEN CORPDAWES KAREN ADirectorAug 29, 2023Option Exercise$33.938,242279,61684,591Aug 30, 2023, 04:06 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DMay 16, 2023Option Exercise$154.03710109,36123,556May 16, 2023, 07:01 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksMay 16, 2023Option Exercise$154.0333451,44632,575May 16, 2023, 07:00 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerMay 16, 2023Option Exercise$154.03710109,36137,381May 16, 2023, 07:00 PM
RGENREPLIGEN CORPMadaus Martin DDirectorMar 24, 2023Option Exercise$186.22112,04811May 08, 2023, 09:15 PM
RGENREPLIGEN CORPMadaus Martin DDirectorMay 04, 2023Buy$161.1550080,575611May 08, 2023, 09:15 PM
RGENREPLIGEN CORPMadaus Martin DDirectorMay 05, 2023Buy$159.1950079,5951,111May 08, 2023, 09:15 PM
RGENREPLIGEN CORPMadaus Martin DDirectorMay 08, 2023Buy$156.1850078,0901,611May 08, 2023, 09:15 PM
RGENREPLIGEN CORPBylund JamesChief Operating OfficerApr 04, 2023Option Exercise$163.4533454,59217,568Apr 04, 2023, 09:37 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerMar 03, 2023Option Exercise$188.003,674690,71238,091Mar 06, 2023, 05:33 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DMar 03, 2023Option Exercise$188.001,247234,43624,266Mar 06, 2023, 05:31 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksMar 03, 2023Option Exercise$188.0012623,68832,909Mar 06, 2023, 05:28 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerMar 03, 2023Option Exercise$188.008,2441,549,872195,307Mar 06, 2023, 05:23 PM
RGENREPLIGEN CORPBylund JamesChief Operating OfficerMar 03, 2023Option Exercise$188.0021039,48017,902Mar 06, 2023, 05:13 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerMar 02, 2023Option Exercise$176.376,6701,176,388165,574Mar 02, 2023, 07:47 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerFeb 28, 2023Option Exercise$173.282,748476,173172,244Mar 02, 2023, 07:47 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksFeb 28, 2023Option Exercise$173.2846079,70929,823Mar 02, 2023, 05:55 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksMar 02, 2023Option Exercise$174.37630109,85329,193Mar 02, 2023, 05:55 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DFeb 28, 2023Option Exercise$173.2835862,03418,454Mar 01, 2023, 05:32 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerFeb 28, 2023Option Exercise$173.2852190,27928,122Mar 01, 2023, 05:22 PM
RGENREPLIGEN CORPBylund JamesChief Operating OfficerFeb 28, 2023Option Exercise$173.44594103,0239,139Feb 28, 2023, 07:54 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerFeb 28, 2023Option Exercise$173.443,273567,669174,992Feb 28, 2023, 07:53 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerFeb 28, 2023Option Exercise$173.44682118,28628,643Feb 28, 2023, 07:53 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DFeb 28, 2023Option Exercise$173.4445879,43618,812Feb 28, 2023, 07:46 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksFeb 28, 2023Option Exercise$173.4445278,39530,283Feb 28, 2023, 07:46 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerFeb 16, 2023Sale$200.005,6471,129,40029,325Feb 17, 2023, 04:56 PM
RGENREPLIGEN CORPEGLINTON MANNER CARRIEDirectorMar 16, 2022Buy$175.02625109,3882,106Dec 15, 2022, 06:55 AM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerNov 11, 2022Option Exercise$116.9350,0005,846,750203,265Nov 14, 2022, 05:43 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerOct 07, 2022Option Exercise$59.5246627,73634,972Oct 11, 2022, 05:00 PM
RGENREPLIGEN CORPDAWES KAREN ADirectorSep 09, 2022Sale$227.17775176,05776,401Sep 09, 2022, 04:14 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerSep 08, 2022Sale$172.3036,4026,272,138204,667Sep 09, 2022, 04:14 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerAug 16, 2022Sale$202.0710,7152,165,14841,204Aug 17, 2022, 04:41 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DAug 11, 2022Sale$162.138,8401,433,19624,110Aug 12, 2022, 04:49 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksAug 04, 2022Sale$243.013,357815,78530,735Aug 05, 2022, 04:29 PM
RGENREPLIGEN CORPBylund JamesChief Operating OfficerAug 03, 2022Option Exercise$167.364,000669,46011,733Aug 04, 2022, 04:32 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerAug 01, 2022Sale$220.002,000440,00037,187Aug 02, 2022, 05:26 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerJul 21, 2022Sale$125.0344,9565,620,740219,469Jul 22, 2022, 04:25 PM
RGENREPLIGEN CORPDAWES KAREN ADirectorMay 25, 2022Sale$150.5114,7152,214,81988,671May 26, 2022, 05:17 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DMay 13, 2022Option Exercise$150.40712107,08520,110May 17, 2022, 05:00 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksMay 13, 2022Option Exercise$150.4033550,38434,092May 17, 2022, 04:59 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerMay 13, 2022Option Exercise$150.40712107,08539,187May 17, 2022, 04:59 PM
RGENREPLIGEN CORPBylund JamesChief Operating OfficerApr 01, 2022Option Exercise$188.0233562,9879,733Apr 04, 2022, 05:57 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerMar 08, 2022Option Exercise$41.344,166172,24239,899Mar 09, 2022, 08:02 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerMar 01, 2022Option Exercise$194.067,2921,415,086199,315Mar 03, 2022, 03:52 PM
RGENREPLIGEN CORPRYAN THOMAS F JRDirectorMar 01, 2022Sale$144.943,000434,8203,457Mar 02, 2022, 09:14 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DFeb 28, 2022Option Exercise$196.702,057404,61220,822Mar 02, 2022, 08:19 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DFeb 27, 2022Option Exercise$196.7047793,82618,645Mar 02, 2022, 08:19 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerFeb 27, 2022Option Exercise$196.70695136,70632,940Mar 02, 2022, 07:52 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerFeb 28, 2022Option Exercise$196.703,129615,47435,733Mar 02, 2022, 07:52 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerFeb 27, 2022Option Exercise$196.702,754541,712193,071Mar 02, 2022, 07:49 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerFeb 28, 2022Option Exercise$196.7016,5383,253,025206,607Mar 02, 2022, 07:49 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksFeb 28, 2022Option Exercise$196.70598117,62734,427Mar 02, 2022, 07:47 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksFeb 27, 2022Option Exercise$196.7046290,87535,025Mar 02, 2022, 07:47 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerFeb 24, 2022Option Exercise$189.211,170221,376195,825Feb 28, 2022, 08:04 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerFeb 24, 2022Option Exercise$189.2126950,89733,635Feb 28, 2022, 07:10 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DFeb 24, 2022Option Exercise$189.2118835,57119,122Feb 28, 2022, 07:10 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksFeb 24, 2022Option Exercise$189.2118134,24735,487Feb 28, 2022, 07:09 PM
RGENREPLIGEN CORPBylund JamesChief Operating OfficerFeb 24, 2022Option Exercise$189.2118835,57110,068Feb 28, 2022, 07:07 PM
RGENREPLIGEN CORPBylund JamesChief Operating OfficerFeb 17, 2022Option Exercise$182.4233460,9286,890Feb 22, 2022, 07:37 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DFeb 17, 2022Option Exercise$182.4217531,92317,184Feb 22, 2022, 07:34 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksFeb 17, 2022Option Exercise$182.4222440,86233,544Feb 22, 2022, 07:31 PM
RGENREPLIGEN CORPSnodgres JonChief Financial OfficerFeb 17, 2022Option Exercise$182.4233260,56330,461Feb 22, 2022, 07:30 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DDec 14, 2021Option Exercise$252.53445112,37616,909Dec 15, 2021, 09:30 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerNov 18, 2021Sale$187.4927,3555,128,674199,495Nov 19, 2021, 04:45 PM
RGENREPLIGEN CORPDAWES KAREN ADirectorNov 10, 2021Sale$145.029,5661,387,28796,030Nov 12, 2021, 05:12 PM
RGENREPLIGEN CORPRYAN THOMAS F JRDirectorNov 02, 2021Option Exercise$215.092,570552,78114,622Nov 04, 2021, 05:45 PM
RGENREPLIGEN CORPRYAN THOMAS F JRDirectorNov 04, 2021Sale$288.001,000288,00012,337Nov 04, 2021, 05:45 PM
RGENREPLIGEN CORPDAWES KAREN ADirectorNov 02, 2021Sale$303.942,400729,46793,583Nov 04, 2021, 05:41 PM
RGENREPLIGEN CORPBARTHELEMY NICOLASDirectorOct 29, 2021Sale$218.022,930638,7973,192Nov 02, 2021, 05:07 PM
RGENREPLIGEN CORPDAWES KAREN ADirectorSep 14, 2021Sale$294.2627480,62893,908Sep 15, 2021, 05:46 PM
RGENREPLIGEN CORPHunt AnthonyChief Executive OfficerSep 09, 2021Sale$163.5750,0008,178,650214,495Sep 13, 2021, 06:24 PM
RGENREPLIGEN CORPGebski ChristineSee RemarksSep 01, 2021Sale$285.333,377963,55933,318Sep 02, 2021, 04:33 PM
RGENREPLIGEN CORPDAWES KAREN ADirectorSep 01, 2021Sale$161.346,9181,116,12897,380Sep 02, 2021, 04:29 PM
RGENREPLIGEN CORPKURIYEL RALFSenior VP, R&DAug 30, 2021Sale$282.134,0011,128,80217,354Sep 02, 2021, 06:54 AM
RGENREPLIGEN CORPDAWES KAREN ADirectorAug 17, 2021Sale$253.7717,5144,444,561111,953Aug 19, 2021, 04:42 PM
RGENREPLIGEN CORPDAWES KAREN ADirectorAug 18, 2021Sale$259.131,442373,65895,061Aug 19, 2021, 04:42 PM
RGENREPLIGEN CORPRYAN THOMAS F JRDirectorAug 04, 2021Sale$250.50780195,390971Aug 05, 2021, 07:33 PM
RGENREPLIGEN CORPDAWES KAREN ADirectorJul 20, 2021Sale$202.094,585926,605117,174Jul 22, 2021, 08:25 PM
RGENREPLIGEN CORPDAWES KAREN ADirectorJul 13, 2021Sale$96.214,449428,040118,982Jul 22, 2021, 06:53 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe